Prometeo: Epidemiological registry for chronic pain
Journal of Developing Drugs

Journal of Developing Drugs
Open Access

ISSN: 2329-6631

+44 20 3868 9735

Prometeo: Epidemiological registry for chronic pain

4th International Summit on GMP, GCP & Quality Control

October 26-28, 2015 Hyderabad, India

Silvia Ussai

Medigenia srl Distretto BioHighTech FVG, Italy

Posters-Accepted Abstracts: J Develop Drugs

Abstract :

Prometeo is the first european digital registry representing the health status of patients suffering from pain based on collecting and integrating all the relevant medical/health information available for a patient and including processing data, prediction and decision helped by computer modeling and simulation of clinical cases, shared by healthcare professionals in Europe. Using Clinical Decision Support Systems (CDSS), the Registry also facilitates pain research and clinical trials, providing clinical outcome data and performance measures to determine the effectiveness of the policy in improving pain care for beneficiaries enrolled in the project. Prometo helps the detection of patients suffering from chronic pain in Europe by both automated transmission of the clinical parameters to an electronic patient record and the use of unobtrusive wearable user-friendly tools that track the patient├ó┬?┬?s condition continuously. Prometeo enables new clinical information to be generated by the blending and fusing of existing data but, ultimately, it leads to the creation of a real avatar capable of supporting the medical professional by producing the new clinical knowledge which will emerge from the integration of patient-specific and population-specific information. Only by continuing to create value through innovation can we continue to redefine the standard of care and continue to improve health outcomes.

Biography :

Email: [email protected]